From Medscape Ophthalmology

Medscape Medical News from the

Association for Research in Vision and Ophthalmology (ARVO) 2014 Annual Meeting

May 04 - 08, 2014; Orlando, Florida

This coverage is not sanctioned by, nor a part of, the Association for Research in Vision and Ophthalmology.

Conference News

ARVO Regimen, Choice of Drug Can Affect AMD Treatment Outcomes
Medscape Medical News, May 30, 2014
$Microstent Standalone Treatment Improves Refractory Glaucoma$ ARVO Microstent Standalone Treatment Improves Refractory Glaucoma
Medscape Medical News, May 28, 2014
ARVO Low-Power Annual SLT Effective for Ocular Hypertension
Medscape Medical News, May 19, 2014
ARVO SLT Shows Benefit for Glaucoma in Afro-Caribbean Patients
Medscape Medical News, May 16, 2014

ARVO Indoor Lifestyle Linked to Myopia in Children
Medscape Medical News, May 15, 2014
ARVO Metformin Linked to Reduced Risk for Glaucoma
Medscape Medical News, May 13, 2014
ARVO Patients With PVD Need Fewer Anti-VEGF Injections
Medscape Medical News, May 12, 2014
ARVO Aflibercept Injections Superior to Laser for Macular Edema
Medscape Medical News, May 8, 2014

Medscape Ophthalmology© WebMD, LLC

Expert Commentary

How Far Would You Go for Science?
Roger F. Steinert, MD

Previous Coverage